EX0096 Pill — PURPLE OVAL, 17mm — Folic Acid

No photo available
View full Folic Acid profile
ImprintEX0096
ColourPURPLE
ShapeOVAL
Size17
StrengthVitamin A 1100 [iU];Ascorbic Acid 60 mg;Vitamin D 1000 [iU];.Alpha.-Tocopherol 20 [iU];Thiamine Mononitrate 1.6 mg;Riboflavin 1.8 mg;Niacin 15 mg;Pyridoxine Hydrochloride 2.5 mg;Folic Acid 1 mg;Cyanocobalamin 25 ug;Iodine 150 ug;Iron 90 mg;Magnesium 20 mg;Zinc 25 mg;Copper 2 mg;Doconexent 200 mg
Dosage formCapsule, Liquid Filled
ManufacturerExeltis USA, Inc.
NDC0642-0096
Schedule—
Availability—
IngredientsVitamin A[Vitamin A];Ascorbic Acid[Ascorbic Acid];Vitamin D[Cholecalciferol];.Alpha.-Tocopherol[.Alpha.-Tocopherol];Thiamine Mononitrate[Thiamine Ion];Riboflavin[Riboflavin];Niacin[Niacin];Pyridoxine Hydrochloride[Pyridoxine];Folic Acid[Folic Acid];Cyanocobalamin[Cyanocobalamin];Iodine[Iodine];Iron[Iron];Magnesium[Magnesium];Zinc[Zinc];Copper[Copper];Doconexent[Doconexent]

What does this imprint mean?

The imprint "EX0096" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Folic Acid

Uses and warnings

No boxed warning. Key warning: "administration of folic acid alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient" - doses above 0.1 mg daily may correct the blood picture while neurologic damage from B12 deficiency continues to progress, so B12 deficiency must be excluded before treating with folic acid alone. The label also notes folic acid may antagonize phenytoin's anticonvulsant action.

Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Folic Acid

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 0b5e21c3-371b-409d-ba8a-0cf85f69d242.xml